Organiser:Informa Markets Time: January 27 – 30, 2025 Address:Sheikh Zayed Road Convention Gate Dubai, UAE – United Arab Emirates Exhibition hall:Dubai World Trade Centre Product range: Medical Devices & Equipment: Medical electronic equipment, medical ultrasound equipment, medical X-ray equipment, medical optical instruments, clinical laboratory analysis instruments, dental equipment and materials, operating room, emergency room, and consulting room equipment and appliances, disposable medical supplies, medical dressings and hygienic materials, various surgical instruments, medical healthcare equipment and supplies, traditional Chinese medicine instruments and rehabilitation appliances, hemodialysis equipment, anesthesia and respiratory equipment, etc. Household Healthcare Products & Small Healthcare Devices: Household health and wellness products, small household diagnostic, monitoring, and treatment instruments, rehabilitation/physiotherapy instruments and supplies, electronic medical instruments, dental appliances, hospital office supplies, sports medicine supplies. Bulk Drugs, Proprietary Chinese Medicines, Pharmaceuticals & Healthcare: Therapeutic, rehabilitative, and healthcare products and supplies with Oriental medicine characteristics. About SLAS: The Arab Health Exhibition ...
Yesterday (October 17th), Abbott announced its third quarter 2024 financial report on its official WeChat account. Abbott’s global sales in the third quarter reached 10.6 billion US dollars (approximately 75.48 billion yuan), with an organic growth of 8.2% and a reported sales growth of 4.9%. Based on the brilliant performance in this quarter, Abbott said that after excluding the impact of COVID-19 testing products, the company expects global sales to achieve an organic growth of 9.5% to 10.0% in 2024, and diluted earnings per share after adjustment for the whole year may be between 4.64 and 4.70 dollars, the median of the range is higher than the previous estimate. Continuous growth achieved through multiple business operations According to the financial report, Abbott’s multiple departments have achieved business growth. Among them, the medical device department achieved double-digit growth, with global sales reaching $4.7 billion in the third quarter, an organic growth ...
Recently, the National Medical Insurance Administration reported on the unannounced inspection of Wuxi Hongqiao Hospital in Jiangsu Province, and made it clear that the next step will be to guide the Jiangsu Provincial Medical Insurance Administration to conduct a comprehensive investigation in the local area. At the same time, it will organize a special action to severely crack down on fraud and insurance fraud across the country to focus on rectifying the unhealthy trends and corruption problems around the people in the medical insurance field. On October 10, the State Drug Administration issued the “Notice on Rewarding Internal Whistleblowers on Drug and Medical Device Quality and Safety (Draft for Comments)” (hereinafter referred to as the “Reward for Reporting”) for public comments. The “Reward for Reporting” clearly states that the announcement applies to reporting major violations of drug and medical device quality and safety to the drug supervision and management department, ...
Recently, Zoll announced that it has completed the previously announced acquisition of some assets of Vyaire Medical’s ventilator business. In August of this year, these two companies announced this transaction after Vyaire initiated Chapter 11 bankruptcy proceedings. Now that the dust has settled on the acquisition, Zoll will launch Vyaire’s Bellavista, Fabian, LTV, and 3100 HFOV series of ventilators, further expanding its respiratory care product line. It is worth mentioning that Vyaire was an important force in the supply of ventilators during the early stages of the COVID-19 pandemic, but applied for bankruptcy protection due to operational difficulties. And Medtronic also chose to withdraw due to the fact that its ventilator business is no longer profitable. Zoll’s acquisition undoubtedly brings new vitality and hope to the market. 01. The rise and fall of rising stars in ventilators Zoll stated that the acquired product line of ventilators and their related consumables, ...
Another province issued compliance guidelines, 8 behaviors need to be closely watched. On October 14, the Jiangxi Provincial Market Supervision Administration issued the “Compliance Guidelines for Anti-Commercial Bribery in the Pharmaceutical Industry” (hereinafter referred to as the “Guidelines”), becoming another province to issue pharmaceutical compliance guidelines after Fujian and Chongqing. The “Guidelines” are divided into four chapters and 15 articles. The so-called pharmaceutical companies refer to operating entities engaged in the production, research and development, sales and other related commodities and related businesses of medical products such as drugs and medical devices, including but not limited to drug/medical device marketing authorization holders (MAHs), drug/medical device contract research organizations (CROs), drug/medical device contract manufacturing organizations (including CMOs, CDMOs), drug/medical device contract sales organizations (CSOs), and drug/medical device commercial distribution companies. Among them, 8 behaviors that may be suspected of commercial bribery are specifically listed, and pharmaceutical companies and medical and health ...
Danuo Pharmaceutical On October 16, 2024, Danno Pharmaceutical, an investment company of Aurora Borealis, announced the completion of the first batch of delivery for over 300 million RMB in Series E financing. This round of financing is jointly led by Zhongshan Venture Capital and AMR Action Fund, a subsidiary of Zhongshan Investment Holdings. The funds obtained will be used to support the core new drug research and development pipeline, including the late stage clinical trials and commercialization of TNP-2198, a new drug candidate for treating Helicobacter pylori infection, and TNP-2092, a new drug candidate for treating implanted medical device infection. Dr. Ma Zhenkun, founder, chairman, and CEO of Danno Pharmaceuticals, said: We are delighted to receive support from Zhongshan Venture Capital and AMR Fund. Danno Pharmaceuticals is committed to addressing the dual challenges of bacterial resistance and tolerance, providing solutions for bacterial infections and metabolic related diseases that still lack ...
Organiser:MEDICA Time:November 11 – 14, 2024 Address:Ostfach 10 10 06, D-40001 Düsseldorf; Stockum Church Street 61, D-40474, Düsseldorf, Germany Exhibition hall:Düsseldorf Exhibition Center Product range: Medical Equipment: Medical electronic instruments, ultrasound equipment, X-ray devices, medical optical instruments, clinical laboratory analytical instruments, dental equipment and materials, hemodialysis equipment, respiratory equipment, hospital ward and operating room equipment, emergency room equipment, hospital office equipment, laboratory equipment, etc. Disposable Supplies: Disposable medical supplies, dressings and hygienic materials, various surgical instruments, etc. Medical Devices: Healthcare devices, home healthcare products, physiotherapy, plastic surgery techniques, etc. Medical Peripherals: Information and communication technology, medical services, publications, etc. About Africa Health: The MEDICA exhibition in Düsseldorf, Germany, is the largest and most authoritative trade show for hospitals and medical equipment worldwide, ranking first among medical trade exhibitions due to its unparalleled scale and influence. Held annually in Düsseldorf, Germany, MEDICA showcases a wide range of products and ...
Drugdu.com expert’s response: Exporting pharmaceutical products to Vietnam requires a series of certifications to ensure compliance with Vietnamese regulations and legal sale in the Vietnamese market. Here are the primary certification requirements: Ⅰ. Free Sales Certificate (FSC) from the Drug Regulatory Authority and Vietnam Embassy Authentication Free Sales Certificate (FSC) from the Drug Regulatory Authority: Definition: The Free Sales Certificate, also known as the Export Sales Certificate, is an official document issued by the drug regulatory authority, certifying that a particular pharmaceutical product or medical device meets relevant national standards and directives, allowing its free sale within the country and export to other countries. Role: In international trade, the FSC is a crucial document for enhancing a product’s international competitiveness, particularly when exporting to overseas markets like Vietnam, where it validates the legality and quality of the pharmaceutical products. Vietnam Embassy Authentication: Definition: Vietnam Embassy Authentication is an official certification ...
Recently, migraine innovative equipment company ShiraTronics announced the completion of a Series B financing of $66 million (approximately RMB 460 million) to support its innovative migraine treatment system. This round of financing is led by new investor Norwest Venture Partners, with other new investors including Seroba, OSF Ventures, Global BioAccess Fund, and an undisclosed strategic investor. In addition, some existing investors such as U S. Venture Partners, Amzak Health, Treo Ventures, and Aperture Venture Partners also participated in this round of financing. The world’s first medical device to treat migraine ShiraTronics, located in Minneapolis, Minnesota, is a clinical stage medical device company dedicated to developing neurostimulation therapies for chronic migraine patients. It is committed to improving the lives of chronic migraine patients and was awarded the FDA Breakthrough Device designation in 2021. The name migraine is not unfamiliar and is often heard in daily life, so the migraine market is ...
On October 11, Yunnan Baiyao issued the “Announcement on the Appointment of Senior Management Personnel”, appointing Li Shengli as its senior vice president. Li Shengli has held important positions in many pharmaceutical companies, including general manager, president, CEO, and chairman of Jiangsu Wanbang Pharmaceutical Marketing Biochemical Oncology Division, co-president, president, and chairman of Jiangsu Fosun Pharmaceutical Sales Co., Ltd., assistant to the president, vice president, senior vice president, executive president, and chief development officer of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. The joining of Li Shengli once again verified the change in Yunnan Baiyao’s talent training model, from internal talent training to the “internal training + external introduction” dual-channel talent model, to create a high-quality talent team that meets its future development needs. Pharmaceutical companies have established their own talent training and selection system, and the company and employees understand each other, have high loyalty, and there is almost no ...
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.